Title : Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials.

Pub. Date : 2017 Aug 1

PMID : 28460083






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MME reduction by month 3 was $70 greater for tofacitinib- than placebo-treated MTX inadequate responders (P < 0.001); >=23 and 13% reductions from baseline, respectively. tofacitinib metaxin 1 Homo sapiens
2 Conclusion: Tofacitinib treatment had a positive impact on estimated medical expenditure and risk of job loss for RA patients with inadequate response to MTX or TNFi. tofacitinib metaxin 1 Homo sapiens